Refine by
Vaccine Designed Equipment & Supplies
38 equipment items found
by:Evaxion Biotech A/S based inHørsholm, DENMARK
RAVEN is our third proprietary AI platform that brings our unique, machine learning approach to vaccine design and development for viral diseases. RAVEN combines the essential AI tools from our PIONEER platform with structural bioinformatic tools from EDEN to arrive at a novel potent T- and B-cell vaccine design for emerging and ...
Manufactured by:Altimmune Inc. based inGaithersburg, MARYLAND (USA)
An intranasal vaccine designed to provide rapid, stable protection against anthrax after a single administration. It is being developed with the support of the U.S. Biomedical Advanced Research and Development Authority, (“BARDA”) for post-exposure prophylaxis against anthrax following exposure to aerosolized B. anthracis ...
Manufactured by:Auro Vaccines LLC based inPearl River, NEW YORK (USA)
Auro Vaccines is developing a GeneVax prime/VesiculoVax boost therapeutic vaccine for herpes simplex virus type-2. This vaccine is designed to ameliorate disease and transmission by preventing HSV-2 reactivation and ...
Manufactured by:ThaMa-Vet – Manufactured by E. Nechmad Ltd. based inPetach Tikva, ISRAEL
The new generation of the pox vaccinators. Better auction and better absorption of the vaccine in the chicken. 5.0cc Capacity for more than 1000 shots. The Automatic Pox Vaccinator with 2 needles enables you to perform the Fowl Pox Vaccination in one shot by one man. It prevents hand scratches with maximum success. Exclusively ...
Manufactured by:POP Biotechnologies, Inc. (POP BIO) based inBuffalo, NEW YORK (USA)
The SNAP (Spontaneous Nanoliposome Antigen Particleization) platform technology is a unique liposome-based system that functions as a potent vaccine adjuvant designed to address functional and practical limitations facing vaccine ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
With the ongoing development of our NanoFlu™ and RSV F vaccines, a strong rationale exists for developing a combination respiratory vaccine that is designed to protect susceptible populations against both diseases. Although testing is at an early stage, we believe that a combination vaccine against both seasonal influenza ...
Manufactured by:Akshaya Bio Inc. based inEdmonton, ALBERTA (CANADA)
The Chimigen® Platform is a flexible platform vaccine technology designed to elicit both humoral and cellular immune responses in ...
Manufactured by:SureChill based inCardiff, UNITED KINGDOM
The GVR50 AC medical refrigerator, powered by the innovative SureChill technology, ensures precise temperature control with no risk of freezing, making it ideal for storing temperature-sensitive drugs and vaccines. Designed for energy efficiency, it operates on mains electric power at both 220V and 110V, with a holdover time exceeding 7 days and requiring only ...
by:Sumitomo Pharma Oncology, Inc. based inCambridge, MASSACHUSETTS (USA)
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to drive sufficient tumor immunogenicity, leading to poor clinical responses.1 The reason for this may be that previous ...
Manufactured by:Scancell based inOxford, UNITED KINGDOM
ImmunoBody vaccines are designed to generate potent T cell responses capable of a broad anti-tumour effect. They are DNA vaccines that encode a protein in the form of an antibody, but the parts of the antibody that would normally bind to the target protein are replaced with epitopes from a cancer ...
by:CuraVac Europe S.A. based inRixensart, BELGIUM
The MYASTERIX project (2013 – 2018) advanced a Therapeutic Vaccine candidate (designated orphan drug) indicated for myasthenia gravis (MG) to clinical proof of concept ...
Manufactured by:Treos Bio Limited based inLondon, UNITED KINGDOM
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals and ethnicities. PolyPEPI-SCoV-2 vaccine can elicit broad and ...
Manufactured by:Meissa Vaccines, Inc. based inRedwood City, CALIFORNIA (USA)
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and immunity following SARS-CoV-2 infection wanes, so vaccine technologies that enhance immunogenicity are required. ...
Manufactured by:Adaptive Biotechnologies based inSeattle, WASHINGTON (USA)
Our TCR-antigen discovery capabilities may inform the design and development of next-generation vaccines. Adaptive has validated hundreds of immunogenic antigens that can be selected to design differentiated vaccines. Our platform is also used to detect and track vaccine-induced antigen-specific T ...
Manufactured by:Polar Thermal Packaging Ltd based inWarminster, UNITED KINGDOM
The Vaccine – BluKoat Insulated Transport Bag is a cutting-edge solution designed for the secure and efficient transportation of vaccines. This product, designed by Polar Thermal Packaging, offers a sophisticated insulation system using patented Polar Thermal material with a thickness of 45mm to provide effective thermal ...
Manufactured by:LogTag North America Inc. based inLafayette, NEW JERSEY (USA)
The UTREL-16F Vaccine Kit is designed for low temperature monitoring, utilizing a multi-trip low temperature USB PDF LCD data logger to ensure accurate and reliable tracking of vaccine temperatures. The kit is configured to meet stringent regulatory requirements, making it suitable for use in cold chains and biopharmaceutical environments. ...
Manufactured by:OSE Immunotherapeutics based inNantes, FRANCE
CoVepiT, a multi-target and multi-variant vaccine candidate against COVID-19. CoVepiT is a next-generation multi-target, multi-variant vaccine against SARS-CoV-2 in clinical Phase 1. The vaccine candidate was designed using optimized epitopes selected after screening more than 67,000 global SARS-CoV-2 genomes, as well as those of ...
Manufactured by:MadgeTech, Inc. based inWarner, NEW HAMPSHIRE (USA)
The VFC2000 is a simple, low-cost solution for vaccine temperature monitoring compliance. Designed to satisfy all CDC and VFC requirements, the VFC2000 provides highly precise, continuous temperature validation. Featuring a convenient LCD screen, the VFC2000 displays current, minimum, and maximum readings as well as a battery level indicator. ...
Manufactured by:Calder Biosciences, Inc. based inBrooklyn, NEW YORK (USA)
Calder’ protein engineering technology is based on targeted di-tyrosine (DT) crosslinking, which allows proteins to be locked in desired shapes. We apply this methodology to engineer novel vaccines that are locked in the shapes that elicit the most potently protective antibody ...
Manufactured by:Oxford Vacmedix UK Limited based inOxford, UNITED KINGDOM
Tumours can often avoid being targeted by these T Cells by looking like a cell found normally in the body often referred to as “self”. If a group of T Cells can be encouraged to recognise these tumours as foreign and not self then they will attack the tumour and provide an effective treatment against it. Injecting a preparation that stimulates these T Cells effectively vaccinates the ...